Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 5.8 Million USD | -0.35% |
| 2021 | 5.82 Million USD | 3.99% |
| 2020 | 5.6 Million USD | 15.88% |
| 2019 | 4.83 Million USD | -0.52% |
| 2018 | 4.85 Million USD | 54.44% |
| 2017 | 3.14 Million USD | 98.2% |
| 2016 | 1.58 Million USD | -64.02% |
| 2015 | 4.41 Million USD | 79.25% |
| 2014 | 2.46 Million USD | 630.5% |
| 2013 | 336.9 Thousand USD | -53.83% |
| 2012 | 729.76 Thousand USD | 2955.76% |
| 2011 | -25.55 Thousand USD | 6.63% |
| 2010 | -27.36 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 5.94 Million USD | 0.43% |
| 2023 Q3 | 5.98 Million USD | 0.67% |
| 2023 Q1 | 5.92 Million USD | 2.0% |
| 2022 FY | 5.8 Million USD | -0.35% |
| 2022 Q3 | 5.77 Million USD | -0.36% |
| 2022 Q4 | 5.8 Million USD | 0.44% |
| 2022 Q1 | 5.79 Million USD | -0.5% |
| 2022 Q2 | 5.8 Million USD | 0.08% |
| 2021 Q3 | 5.99 Million USD | -1.19% |
| 2021 Q4 | 5.82 Million USD | -2.87% |
| 2021 Q1 | 5.95 Million USD | 6.24% |
| 2021 FY | 5.82 Million USD | 3.99% |
| 2021 Q2 | 6.06 Million USD | 1.99% |
| 2020 Q3 | 5.5 Million USD | 5.28% |
| 2020 Q1 | 5.24 Million USD | 8.56% |
| 2020 Q2 | 5.23 Million USD | -0.29% |
| 2020 FY | 5.6 Million USD | 15.88% |
| 2020 Q4 | 5.6 Million USD | 1.68% |
| 2019 Q4 | 4.83 Million USD | 9.61% |
| 2019 Q1 | 5.48 Million USD | 12.95% |
| 2019 Q2 | 5.96 Million USD | 8.61% |
| 2019 FY | 4.83 Million USD | -0.52% |
| 2019 Q3 | 4.4 Million USD | -26.02% |
| 2018 Q3 | 4.53 Million USD | 10.77% |
| 2018 FY | 4.85 Million USD | 54.44% |
| 2018 Q4 | 4.85 Million USD | 7.22% |
| 2018 Q2 | 4.09 Million USD | 14.92% |
| 2018 Q1 | 3.56 Million USD | 13.16% |
| 2017 Q2 | 2.17 Million USD | 42.0% |
| 2017 Q1 | 1.53 Million USD | -3.42% |
| 2017 FY | 3.14 Million USD | 98.2% |
| 2017 Q4 | 3.14 Million USD | 63.25% |
| 2017 Q3 | 1.92 Million USD | -11.47% |
| 2016 Q4 | 1.58 Million USD | -19.71% |
| 2016 Q2 | 1.49 Million USD | -70.32% |
| 2016 FY | 1.58 Million USD | -64.02% |
| 2016 Q1 | 5.02 Million USD | 13.88% |
| 2016 Q3 | 1.97 Million USD | 32.6% |
| 2015 Q4 | 4.41 Million USD | 14.6% |
| 2015 FY | 4.41 Million USD | 79.25% |
| 2015 Q2 | 3.8 Million USD | 1799.32% |
| 2015 Q3 | 3.84 Million USD | 1.28% |
| 2015 Q1 | -223.67 Thousand USD | -109.09% |
| 2014 Q2 | 3.77 Million USD | 31.54% |
| 2014 Q4 | 2.46 Million USD | -18.24% |
| 2014 Q3 | 3.01 Million USD | -20.29% |
| 2014 Q1 | 2.87 Million USD | 752.15% |
| 2014 FY | 2.46 Million USD | 630.5% |
| 2013 Q4 | 336.9 Thousand USD | -60.89% |
| 2013 Q3 | 861.38 Thousand USD | 21.75% |
| 2013 Q2 | 707.49 Thousand USD | 17.06% |
| 2013 Q1 | 604.37 Thousand USD | -17.18% |
| 2013 FY | 336.9 Thousand USD | -53.83% |
| 2012 FY | 729.76 Thousand USD | 2955.76% |
| 2012 Q1 | 248.09 Thousand USD | 1070.87% |
| 2012 Q2 | 322.25 Thousand USD | 29.89% |
| 2012 Q3 | 497.42 Thousand USD | 54.36% |
| 2012 Q4 | 729.76 Thousand USD | 46.71% |
| 2011 Q3 | 310.15 Thousand USD | 123.52% |
| 2011 FY | -25.55 Thousand USD | 6.63% |
| 2011 Q4 | -25.55 Thousand USD | -108.24% |
| 2011 Q1 | -52.87 Thousand USD | -93.21% |
| 2011 Q2 | 138.76 Thousand USD | 362.41% |
| 2010 FY | -27.36 Thousand USD | 0.0% |
| 2010 Q2 | -5.89 USD | 0.0% |
| 2010 Q4 | -27.36 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 100.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AI/ML Innovations Inc. | -3732.00 CAD | 155630.252% |
| Diagnamed Holdings Corp. | -606.96 Thousand CAD | 1056.3% |
| Pangenomic Health Inc. | 952.18 Thousand CAD | -509.586% |
| nDatalyze Corp. | -794.1 Thousand CAD | 830.938% |
| Treatment.Com International Inc. | -273.39 Thousand CAD | 2223.086% |
| Unidoc Health Corp. | -324.03 Thousand CAD | 1891.312% |